Mandip S. Dhamoon, MD, MPH is an Assistant Professor of Neurology at the Mount Sinai Medical Center. He received a B.A. from Williams College and an M.D. from Mount Sinai School of Medicine. He completed an internship at Jacobi Medical Center, and a neurology residency and fellowship in cerebrovascular disease and neuroepidemiology at Columbia University. He received an MPH from the Mailman School of Public Health and is currently in the dissertation phase of a DrPH degree in epidemiology.
MD, Mount Sinai School of Medicine
Internship, Internal Medicine
Jacobi Hospital Center
Columbia University Medical Center
Fellowship, Stroke & Neuro-Intensive Care
Columbia University Medical Center
Neurology, American Board of Psychiatry and Neurology
Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS. Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study. Annals of epidemiology 2014 May; 24(5).
Dhamoon MS, McClure LA, White CL, Lau H, Benavente O, Elkind MS. Quality of Life after Lacunar Stroke: The Secondary Prevention of Small Subcortical Strokes Study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2013 Oct;.
Lackland DT, Elkind MS, D'Agostino R, Dhamoon MS, Goff DC, Higashida RT, McClure LA, Mitchell PH, Sacco RL, Sila CA, Smith SC, Tanne D, Tirschwell DL, Touzé E, Wechsler LR. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation 2012 Jul; 43(7).
Willey JZ, Petersen N, Dhamoon MS, Stillman J, Boden-Albala B, Elkind MS, Marshall RS. Safety of thrombolysis in patients over the age of 80. The neurologist 2012 Mar; 18(2).
Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS. The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study. Stroke; a journal of cerebral circulation 2011 Oct; 42(10).
Dhamoon MS, Elkind MS. Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation 2010 May; 121(18).
Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Quality of life declines after first ischemic stroke. The Northern Manhattan Study. Neurology 2010 Jul; 75(4).
Dhamoon MS, Lazar RM, Marshall RS. Impairment versus activity limitation after incident ischaemic stroke. International journal of stroke : official journal of the International Stroke Society 2010 Apr; 5(2).
Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke; a journal of cerebral circulation 2009 Aug; 40(8).
Rincon F, Dhamoon M, Moon Y, Paik MC, Boden-Albala B, Homma S, Di Tullio MR, Sacco RL, Elkind MS. Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke; a journal of cerebral circulation 2008 Sep; 39(9).
Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, Elkind MS. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke; a journal of cerebral circulation 2007 Jun; 38(6).
Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS. Trajectory of functional decline before and after ischemic stroke: the Northern Manhattan Study. Stroke; a journal of cerebral circulation 2012 Aug; 43(8).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Dhamoon did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.